Study Summary
This trial will test whether providing patients with information about their risk of kidney failure improves quality of care, health literacy, and trust in the care they are receiving.
- Chronic Kidney Disease
Treatment Effectiveness
Effectiveness Progress
Study Objectives
2 Primary · 10 Secondary · Reporting Duration: 6 months after intervention
Trial Safety
Safety Progress
Trial Design
2 Treatment Groups
Control Group
1 of 2
Active Knowledge Translation Group
1 of 2
Active Control
Experimental Treatment
6300 Total Participants · 2 Treatment Groups
Primary Treatment: Active Knowledge Translation · No Placebo Group · N/A
Trial Logistics
Trial Timeline
Who is running the clinical trial?
Eligibility Criteria
Age 18+ · All Participants · 2 Total Inclusion Criteria
Mark “Yes” if the following statements are true for you:- Harasemiw, Oksana, Neil Drummond, Alexander Singer, Aminu Bello, Paul Komenda, Claudio Rigatto, Jordyn Lerner, Dwight Sparkes, Thomas W. Ferguson, and Navdeep Tangri. 2019. “Integrating Risk-based Care for Patients with Chronic Kidney Disease in the Community: Study Protocol for a Cluster Randomized Trial”. Canadian Journal of Kidney Health and Disease. SAGE Publications. doi:10.1177/2054358119841611.
- Bello, Aminu K., Paul E. Ronksley, Navdeep Tangri, Julia Kurzawa, Mohamed A. Osman, Alexander Singer, Allan Grill, et al.. 2019. “Prevalence and Demographics of CKD in Canadian Primary Care Practices: A Cross-sectional Study”. Kidney International Reports. Elsevier BV. doi:10.1016/j.ekir.2019.01.005.
- Bello, Aminu K., Paul E. Ronksley, Navdeep Tangri, Julia Kurzawa, Mohamed A. Osman, Alexander Singer, Allan K. Grill, et al.. 2019. “Quality of Chronic Kidney Disease Management in Canadian Primary Care”. JAMA Network Open. American Medical Association (AMA). doi:10.1001/jamanetworkopen.2019.10704.
- Navdeep Tangri 2018. "Integrating Risk-based Care for Patients With CKD". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT03365063.
Frequently Asked Questions
Are there any openings for individuals to join this experiment?
"The clinical trial is actively seeking volunteers; the initial posting was made on August 24th 2018, with a recent update seen on June 9th 2022." - Anonymous Online Contributor
What is the scope of enrollees for this experiment?
"Affirmative. According to clinicaltrials.gov, this trial is recruiting and was posted on August 24th 2018 with the latest edit occuring June 9th 2022. Approximately 6300 participants are sought from two separate medical facilities." - Anonymous Online Contributor
What objectives is this experiment seeking to accomplish?
"The principal outcome of this trial, to be evaluated within a year after the intervention, is the proportion of patients who are being treated adequately with ACEi or ARB and have either CKD and diabetes, or CKD plus urine ACR >30 mg/mmol. Subsidiary objectives include assessing clinical providers' satisfaction with risk prediction tools & decision aids (measured by Likert scale points), monitoring cardiovascular risk factors for CKD patients (proportion w/ statin prescription in EMR) & evaluating patient's kidney-related health literacy (number of KiKS survey answers)." - Anonymous Online Contributor